PhaseRx Profile

USD 0.06  13.22%
0.37Last Month High 1.16 
0.4Trading Day  High 0.6 

Acquisition by John Schmidt of 14000 shares of PhaseRx subject to Rule 16b-3

PhaseRx Inc insider trading alert for grant of employee stock option (right to buy) by John Schmidt, the corporate stakeholder, on May 30, 2017. This event was filed by Phaserx Inc with SEC on 2017-05-30. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

PhaseRx Summary

PhaseRx Inc (PZRX) is traded on BATS Exchange in USA. It is located in WASHINGTON, U.S.A and employs 14 people. PhaseRx is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Nano-Cap' category with current market capitalization of 6.31 M. PhaseRx Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 11.69 M outstanding shares of which 8.39 K shares are at this time shorted by private and institutional investors with about 0.05 trading days to cover. PhaseRx currently holds about 5.26 M in cash with (12.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PhaseRx Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

PhaseRx Inc Risk Profiles

Key Fundamentals

PhaseRx Against Markets

Current Ratings  

PhaseRx 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 58% 
PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of mRNA solutions to correct lifethreatening inherited liver diseases in children. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NamePhaseRx Inc
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressPhaseRx, Inc.Seattle, WA
ExchangeBATS Exchange
Contact Number206 805 6300
CurrencyUSD - US Dollar


PhaseRx Analyst Recommendations
Target PriceAdvice# of Analysts
8.0Strong Buy1Odds
PhaseRx Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
PhaseRx Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas